MedStream Designer (MSD)

LEARN MORE ABOUT MSD

An innovative tool for analyzing medical data from the hospital information system.
MedStream Designer is an innovative solution for analyzing data collected in hospital systems. It is fully integrated with the hospital information system and allows you to create any search query based on medical criterias using the intelligently designed graphical user interface.

Search through millions of patient records
Advanced search queries in a modern user interface
Unlimited searching and analyzing patient’s data from EHR

 

WHAT MAKES US DIFFERENT

Search patients based on their treatment history

The unique function of the MSD tool is the ability to search for patients on the basis of their medical history records.
MSD automatically converts the graphical sequence of treatment- related elements into a HIS database query and returns a subset of patients following the given criteria.
Taking into consideration the cause and effect relations between various events of the treatment, MSD is an innovative approach to the search engine of medical information

Intuitive user interface Drag&Drop
which lets you search patients with no IT knwoledge
Predefined dictionaries
to search patients using an ICD10, ICD9, ICD-03
Data analysis which includes searching for patterns of treatment or similar diseases
Dynamic search criterias translation
(based on user action) into natural language
Advanced text search
powered by ElasticSearch engine
Dedicated data cleaning
mechanism which guarantee their consistency
Data visualization module using a wide variety of graphs to help you discover patterns, trends and analyze the distribution of medical data.
Ability to export the resulting data to an XLSX (Excel) or CSV file for further advanced analysis.

DISCOVER ADVANTAGES

MSD has been designed for physicians and managers to take full advantage of data.

1

Benefits for hospital managers

Monitoring the quality of treatment – MSD enables managers to define and monitor the quality of care in a novel way.

Reducing the cost of analysis of large data sets – comprehensive reports available at any time within a few minutes, created with a single easy-to-use tool.

Increase in the utilization of the HIS system – we provide the tool for everyone to analyze hundreds of thousands of medical data including: hospital stays, visits, procedures, diagnosis, given medications, lab results and descriptive data.

2

Benefits for the medical staff

Improvement of quality through searching for the best practice and comparative analysis covering the full range of data from the HIS system.

Support for research projects and scientific papers – MSD reduces the analysis time by up to 80%, making it easier to conduct retrospective studies on a large cohorts of patients

Increase in competence – thanks to MSD doctors can benefit from mutual experience and knowledge. Treatment regimens, unusual cases, medical notes are available with a few clicks for everyone.

3

Benefits for CRO and similar companies

Screening of patients prior to the clinical trial at the hospital – you can quickly discover the hospital’s potential in participating in the study.

Fast, accurate and low cost of selection of patient data – with MSD, we can easily and accurately identify a cohort of patients which meet the inclusion / exclusion criteria of the study.

Research and Observation Programs support – MSD will assist you in conducting observational studies among large groups of patients. MSD reduces the creation time of such reports by up to 90%.

EXAMPLE

Example: Patients diagnosed at any time with C91-C91.9 (Lymphotic Leukemia) who were treated with RFC scheme (Rituximab / Mabthera, Fludarabinum, Cyclophosphamide) and who have had blood tests done at least twice: first time within 7 days from treatment application, second- from 6 to 8 months after the first test.
In addition, it should be checked if those patients were tested for IgG (Immoglobulin G). If so, the result of this test should be included in the patients’ search results.
Screen for the scenario described above, with the preview of parameters/search criteria.

Example: Patients diagnosed at any time with C91-C91.9 (Lymphotic Leukemia) who were treated with RFC scheme (Rituximab / Mabthera, Fludarabinum, Cyclophosphamide) and who have had blood tests done at least twice: first time within 7 days from treatment application, second- from 6 to 8 months after the first test.
In addition, it should be checked if those patients were tested for IgG (Immoglobulin G). If so, the result of this test should be included in the patients’ search results.
Drug selection screen. Such a detailed screen is shown for each parameter, obviously with other search criteria for diagnoses, drugs, procedures etc.

Example: Patients diagnosed at any time with C91-C91.9 (Lymphotic Leukemia) who were treated with RFC scheme (Rituximab / Mabthera, Fludarabinum, Cyclophosphamide) and who have had blood tests done at least twice: first time within 7 days from treatment application, second- from 6 to 8 months after the first test.
In addition, it should be checked if those patients were tested for IgG (Immoglobulin G). If so, the result of this test should be included in the patients’ search results.
Screen showing detailed information associated with particular patient. Patient’s history contains all of these items that were the search criteria (applied drug, blood test etc.)
Example: Patients diagnosed at any time with C91-C91.9 (Lymphotic Leukemia) who were treated with RFC scheme (Rituximab / Mabthera, Fludarabinum, Cyclophosphamide) and who have had blood tests done at least twice: first time within 7 days from treatment application, second- from 6 to 8 months after the first test.
In addition, it should be checked if those patients were tested for IgG (Immoglobulin G). If so, the result of this test should be included in the patients’ search results.
Screen presenting a statistical overview of age and sex for the selected group of patients.

SEE DEMO MOVIES

DOWNLOAD PRODUCT BROCHURE